From Name:
From Email:
To Name:
To Email:

Optional Message:


Gene-Editing Cardiovascular Therapy Startup Licenses CRISPR Patents, Partners with Beam

from Genetic Engineering & Biotechnology News

A developer of gene editing-based therapies launched today with $58.5 million in Series A financing, will license CRISPR patents from the Broad Institute and Harvard University, and partner with Beam Therapeutics, to develop cardiovascular treatments based on editing the adult human genome. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063